Non-Invasive Prenatal Testing (NIPT) Market Size, Share, Growth Report 2032

Non-Invasive Prenatal Testing (NIPT) Market Insights

According to a report from Zion Market Research, the global Non-Invasive Prenatal Testing (NIPT) Market was valued at USD 6.29 Billion in 2023 and is projected to hit USD 19.21 Billion by 2032, with a compound annual growth rate (CAGR) of 13.2% during the forecast period 2024-2032. This report explores market strengths, weakness, opportunities, and threats. It also provides valuable insights into the market's growth drivers, challenges, and the future prospects that may emerge in the Non-Invasive Prenatal Testing (NIPT) Market industry over the next decade.Request Free Sample

Market Overview     

The global Non-Invasive Prenatal Testing (NIPT) market accounted for USD 921 Million in 2020 and is expected to reach USD 1582 Million by 2028, growing at a CAGR of around 6.7% between 2021 and 2028.

Non-invasive prenatal testing is a complicated technology that helps determine fetal chromosomal anomalies by analyzing the fetus's cell-free DNA. because the invasive procedures have a better risk quotient, including the danger of fetal loss, most healthcare professionals prefer non-invasive techniques. NIPTs are new genetic tests that use cell-free circulating fetal DNA within the maternal serum to screen for more common fetal aneuploidies, like mongolism, trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome), and monosomy X (Turner syndrome). With increased patient access to healthcare information also as advertising, the NIPT market is anticipated to possess a positive outlook within the coming years.

Request Free Sample

COVID-19 Impact Analysis  

Besides, the COVID-19 outbreak, there's a drastic rise in the demand for healthcare facilities across the world. 2020 has been a dramatic rush of hospital visits and checkups so far, all because of a pandemic that has shaken the entire world. The Novel Coronavirus that caused the COVID-19 disease unleashed a disaster of extraordinary proportions. As healthcare spends for COVID-19 increases exponentially, companies that conduct research, develop potential vaccines, produce test kits, and manufacture or supply medical equipment are likely to benefit the most. The reason is clear - governments across the world will invest in not only damage control, but also in the prevention of any potential resurgence of the pandemic. This also means that companies other than those manufacturing types of equipment or infrastructure support that are not directly connected to COVID-19 would face disruptions in business.

Growth Factors

 Advantages offered by NIPT like non-invasiveness, high accuracy, and early detection, raising awareness, increasing penetration in highly untapped countries in Asia and Latin America, and continuous increase in average maternal age are the main factors expected to drive the expansion of the worldwide NIPT market during the forecast period. However, the market is additionally facing significant ethical and regulatory hurdles related to the implementation of NIPT due to the assumption that it's likely to extend the incidence of abortions. Therefore, various professional organizations like the American College of Obstetricians and Gynecologists (ACOG), the International Society for a diagnostic procedure, the Japan Society of Obstetrics and Gynecology, and genetic counselors across the planet have found out guidelines that limit the utilization of non-invasive prenatal testing only to pregnant women at high risk of chromosomal aneuploidies.

Non-Invasive Prenatal Testing (NIPT) Market: Report Scope

Segment Analysis Preview  

Based on test type the market is segmented into panel 1, panel 2 and panel 3. Based on end-user, the worldwide marketplace for OR equipment is segmented into hospitals, diagnostic centers, and maternity clinics. Diagnostic centers have accounted for the main share of this segment in 2018 due to the increased investments in healthcare infrastructure & the use of advanced technologies. The increasing incidence of chromosomal abnormalities coupled with growing product usage in new applications is driving the organic revenue growth in the market. Additionally, increasing demand for patient satisfaction, cost-effective procedures, and efficient practices by healthcare professionals also are expected to spice up the expansion of this market within the forecast period.

Regional Analysis Preview

Based on geography, North America held the most important share of the worldwide NIPT market in terms of revenue. Major players domiciled within the U.S. and comparatively high awareness levels about NIPT in North America are the key factors attributed to the region’s leadership position. In Europe, market growth largely depends upon the increasing penetration of those U.S.-based test developers and an increase in acceptance of those tests. Japan, Australia, China, and India represent high growth potential markets in Asia-Pacific. The NIPT market in China is dominated by two local players BGI Diagnostics and Berry Genomics. Additionally, the recent CFDA approval for Bambini Test would propel the expansion of the market during this region.

Request Free Sample

Key Market Players & Competitive Landscape

The major players that are comprised in  Non-Invasive Prenatal Testing (NIPT) market are Ariosa Diagnostics, Inc., Berry Genomics Co., Ltd, BGI Diagnostics, Illumina, Inc., LifeCodexx AG, Natera, Inc., Sequenom Laboratories, and Quest Diagnostics, Inc. The market is saturated with few players operating in the NIPT space and these companies are expected to compete on the grounds of cost and functionality. Product differentiation, new product launches and merger and acquisition are some of the strategies adopted by these industry participants. 

Request Free Sample

The global  Non-Invasive Prenatal Testing (NIPT) Market is segmented as follows:

By Test Type

• Panel 1
• Panel 2
• Panel 3

By End-User

• Hospitals
• Diagnostic Centers
• Maternity Clinics

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa